170 related articles for article (PubMed ID: 8953109)
1. Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles.
Claros MC; Citron DM; Hunt Gerardo S; Goldstein EJ; Schönian G; Montag T; Hampel B; Rodloff AC
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S66-72. PubMed ID: 8953109
[TBL] [Abstract][Full Text] [Related]
2. Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States.
Claros MC; Hunt Gerardo S; Citron DM; Goldstein EJ; Schönian G; Rodloff AC
Clin Infect Dis; 1997 Sep; 25 Suppl 2():S295-8. PubMed ID: 9310712
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
4. Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples.
Tong J; Liu C; Summanen P; Xu H; Finegold SM
Anaerobe; 2011 Apr; 17(2):64-8. PubMed ID: 21439390
[TBL] [Abstract][Full Text] [Related]
5. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.
Snydman DR; McDermott L; Cuchural GJ; Hecht DW; Iannini PB; Harrell LJ; Jenkins SG; O'Keefe JP; Pierson CL; Rihs JD; Yu VL; Finegold SM; Gorbach SL
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S54-65. PubMed ID: 8953108
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
[TBL] [Abstract][Full Text] [Related]
7. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.
Rashidan M; Azimirad M; Alebouyeh M; Ghobakhlou M; Asadzadeh Aghdaei H; Zali MR
Anaerobe; 2018 Apr; 50():93-100. PubMed ID: 29454108
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
Bandoh K; Ueno K; Watanabe K; Kato N
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
[TBL] [Abstract][Full Text] [Related]
9. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers.
Liu C; Song Y; McTeague M; Vu AW; Wexler H; Finegold SM
FEMS Microbiol Lett; 2003 May; 222(1):9-16. PubMed ID: 12757940
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and antimicrobial resistance of B. fragilis group organisms isolated from clinical specimen and human intestinal microbiota.
de Carvalho CB; Moreira JL; Ferreira MC
Rev Inst Med Trop Sao Paulo; 1996; 38(5):329-35. PubMed ID: 9293074
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of Bacteroides fragilis group species by leuB-directed PCR.
Miki T; Kuwahara T; Nakayama H; Okada N; Kataoka K; Arimochi H; Ohnishi Y
J Med Invest; 2005 Feb; 52(1-2):101-8. PubMed ID: 15751280
[TBL] [Abstract][Full Text] [Related]
13. Emergence and evolution of an international cluster of MDR Bacteroides fragilis isolates.
Sóki J; Hedberg M; Patrick S; Bálint B; Herczeg R; Nagy I; Hecht DW; Nagy E; Urbán E
J Antimicrob Chemother; 2016 Sep; 71(9):2441-8. PubMed ID: 27246231
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates.
Claros MC; Claros ZC; Hecht DW; Citron DM; Goldstein EJ; Silva J; Tang-Feldman Y; Rodloff AC
Anaerobe; 2006 Feb; 12(1):17-22. PubMed ID: 16701608
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
Eitel Z; Sóki J; Urbán E; Nagy E;
Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
Borobio MV; Domínguez MC; Pallares JA; Perea EJ
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
[TBL] [Abstract][Full Text] [Related]
17. Characterization of beta-lactam-resistant Bacteroides fragilis isolates by use of PCR fingerprinting.
Fang H; Hedberg M; Edlund C; Jarstrand C; Fodor E; Nord CE
Anaerobe; 1999 Feb; 5(1):11-8. PubMed ID: 16887657
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of the subspecies of Bacteroides fragilis.
Blazevic DJ
Antimicrob Agents Chemother; 1976 Mar; 9(3):481-4. PubMed ID: 1259403
[TBL] [Abstract][Full Text] [Related]
19. Variation in the susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals.
Hecht DW; Osmolski JR; O'Keefe JP
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S357-60. PubMed ID: 8324147
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey.
Kangaba AA; Saglam FY; Tokman HB; Torun M; Torun MM
Anaerobe; 2015 Oct; 35(Pt B):72-6. PubMed ID: 26219215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
